Literature DB >> 11680587

Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy.

S W Kim1, K H Kim, S J Park, H H Her, J Y Jang, Y H Park.   

Abstract

The purpose of this study was to evaluate the effect of endogenous gastrin on pancreatic regeneration after a partial pancreatectomy in the rat. Sixty rats were divided into 6 groups. Groups I and II received sham operation (splenectomy only), and groups III, IV, V, and VI received both 66% partial pancreatectomy (PPx) and splenectomy. Endogenous hypergastrinemia was induced in groups II, IV, and VI by gavage of Lansoprozole (LSP) for three weeks. In groups V and VI, gastrin receptor blocker, L365,260, was given continuously using an osmotic minipump. Following three weeks of treatment, PPx alone increased the pancreatic weight and protein content, but not RNA or DNA content (Group III). In the PPx groups, the pancreatic weight, and contents of protein, RNA, and DNA were significantly increased in the LSP treated rats (Group IV). This effect was abolished by L365,260 (Group VI). This results suggest that endogenous gastrin specifically stimulates regeneration of the remnant pancreas after partial pancreatectomy in rat. Induction of endogenous hypergastrinemia may be useful in patients following pancreatic resection for the prevention and treatment of pancreatic insufficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680587     DOI: 10.1023/a:1011946411646

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  SEGMENTAL DIVISION OF THE RAT PANCREAS FOR EXPERIMENTAL PROCEDURES.

Authors:  C RICHARDS; P J FITZGERALD; B CAROL; L ROSENSTOCK; L LIPKIN
Journal:  Lab Invest       Date:  1964-10       Impact factor: 5.662

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

Review 3.  Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum.

Authors:  J F Rehfeld
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

4.  Production and evaluation of antibodies for the radioimmunoassay of gastrin.

Authors:  J F Rehfeld; F Stadil; B Rubin
Journal:  Scand J Clin Lab Invest       Date:  1972-10       Impact factor: 1.713

5.  Influence of chronic administration of pentagastrin on the pancreas in hypophysectomized rats.

Authors:  P D Mayston; J A Barrowman
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

6.  New aspects of the trophic action of gastrointestinal hormones.

Authors:  L R Johnson
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

7.  Pancreatic hyperplasia after small bowel resection in the rat: dissociation from endogenous gastrin levels.

Authors:  C Stock-Damgé; M Aprahamian; E Lhoste; A Pousse; W Humbert; R Noriega; J F Grenier
Journal:  Digestion       Date:  1984       Impact factor: 3.216

8.  Proglumide inhibition of trophic action of pentagastrin.

Authors:  L R Johnson; P D Guthrie
Journal:  Am J Physiol       Date:  1984-01

9.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

Review 10.  Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors.

Authors:  S P Povoski; W Zhou; D S Longnecker; R T Jensen; S A Mantey; R H Bell
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  1 in total

1.  Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans.

Authors:  Jin-Young Jang; Sun-Whe Kim; Joon-Koo Han; Sang-Jae Park; Youn-Chan Park; Young Joon Ahn; Yong-Hyun Park
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.